Cancer metastasis: molecular mechanisms and clinical perspectives

SU Khan, K Fatima, F Malik, H Kalkavan… - Pharmacology & …, 2023 - Elsevier
Metastatic progression combined with non-responsiveness towards systemic therapy often
shapes the course of disease for cancer patients and commonly determines its lethal …

NSAIDs and cancer resolution: new paradigms beyond cyclooxygenase

OR Kolawole, K Kashfi - International journal of molecular sciences, 2022 - mdpi.com
Acute inflammation or resolved inflammation is an adaptive host defense mechanism and is
self-limiting, which returns the body to a state of homeostasis. However, unresolved …

[HTML][HTML] Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

A Cortellini, M Tucci, V Adamo, LS Stucci… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Concomitant medications, such as steroids, proton pump inhibitors (PPI) and
antibiotics, might affect clinical outcomes with immune checkpoint inhibitors. Methods We …

Key matrix remodeling enzymes: functions and targeting in cancer

Z Piperigkou, K Kyriakopoulou, C Koutsakis… - Cancers, 2021 - mdpi.com
Simple Summary Proteolytic enzymes, such as matrix metalloproteinases, plasminogen
activators and cathepsins, as well as non-proteolytic enzymatic partners, such as …

Opposing functions of heparanase-1 and heparanase-2 in cancer progression

I Vlodavsky, M Gross-Cohen, M Weissmann… - Trends in biochemical …, 2018 - cell.com
Heparanase, the sole heparan sulfate (HS)-degrading endoglycosidase, regulates multiple
biological activities that enhance tumor growth, metastasis, angiogenesis, and inflammation …

Complex roles of the old drug aspirin in cancer chemoprevention and therapy

H Hua, H Zhang, Q Kong, J Wang… - Medicinal research …, 2019 - Wiley Online Library
The nonsteroidal anti‐inflammatory agent aspirin is widely used for preventing and treating
cardiovascular and cerebrovascular diseases. In addition, epidemiologic evidences reveal …

Exosomes and their role in cancer progression

Y Liu, K Shi, Y Chen, X Wu, Z Chen, K Cao… - Frontiers in …, 2021 - frontiersin.org
Exosomes from extracellular vesicles can activate or inhibit various signaling pathways by
transporting proteins, lipids, nucleic acids and other substances to recipient cells. In …

Corilagin alleviates LPS-induced sepsis through inhibiting pyroptosis via targeting TIR domain of MyD88 and binding CARD of ASC in macrophages

S Wu, J Liao, G Hu, L Yan, X Su, J Ye, C Zhang… - Biochemical …, 2023 - Elsevier
Sepsis is a dysregulated systemic inflammatory response caused by infection that leads to
multiple organ injury and high mortality without effective treatment. Corilagin, a natural …

Targeting heparanase in cancer: inhibition by synthetic, chemically modified, and natural compounds

CD Mohan, S Hari, HD Preetham, S Rangappa… - Iscience, 2019 - cell.com
Heparanase is an endoglycosidase involved in remodeling the extracellular matrix and
thereby in regulating multiple cellular processes and biological activities. It cleaves heparan …

Aspirin use and common cancer risk: a meta-analysis of cohort studies and randomized controlled trials

L Wang, R Zhang, L Yu, J Xiao, X Zhou, X Li… - Frontiers in …, 2021 - frontiersin.org
Background Whether aspirin use can decrease or increase cancer risk remains
controversial. In this study, a meta-analysis of cohort studies and randomized controlled …